Corporate Accountability Project | Thrasio · Product Safety · 2026
Public Health
Case 2:26-cv-01176 • C.D. Cal.
Thrasio Sold 1.5 Million Bacteria-Laced Cleaning Products for Six Years
Angry Orange Enzyme Stain Remover, marketed as safe for children and pets, was contaminated with dangerous bacteria while the company said nothing.
● Critical Severity
TL;DR
For nearly six years, from March 2019 through December 2025, Thrasio manufactured and sold Angry Orange Enzyme Stain Remover contaminated with Pseudomonas aeruginosa, a bacterium that can cause serious infections, particularly in people with weakened immune systems, underlying lung conditions, or external medical devices. The bacteria can enter the body through inhalation, the eyes, or broken skin. While Thrasio’s own website claimed the product was “chemical-free” and “safe to use around your home,” approximately 1.5 million bottles were silently spreading contamination through households across the country. A voluntary recall was not announced until January 22, 2026, and even then, the company’s refund process was structured in a way that effectively denied most consumers a meaningful remedy.
This is not a manufacturing accident. This is six years of failed testing, failed oversight, and a failed recall. Demand full accountability.
Key Numbers at a Glance
1.5M
Bottles recalled across the U.S.
~6 yrs
Contaminated products manufactured (2019 to 2025)
$4-$60
Price range paid by consumers
$5M+
Minimum class action value threshold
The Allegations: A Full Breakdown
Core Allegations
What Thrasio did
| 01 | Thrasio manufactured and distributed approximately 1.5 million bottles of Angry Orange Enzyme Stain Remover contaminated with Pseudomonas aeruginosa, a dangerous bacterium capable of causing severe infections. | high |
| 02 | Contaminated products were produced across a six-year period, from March 2019 through December 2025, and entered commerce at nationwide retailers including Walmart, Target, Home Depot, Meijer, Staples, and TJ Maxx, and online at Amazon, Walmart.com, Target.com, and Chewy.com. | high |
| 03 | Thrasio publicly claimed its Angry Orange product was “chemical-free” and that “keeping your children and pets safe is our priority.” These statements were materially false. The product posed a documented bacterial health risk to anyone in the household. | high |
| 04 | The recalled products came in 24-oz, 32-oz, and 1-gallon sizes in Fresh Clean Scent and Orange Twist Scent, some bundled with UV light accessories, sold for between $4 and $60 per unit. | med |
| 05 | The contamination was sufficiently widespread that every unit subject to the recall, regardless of lot, was plausibly affected by the defect. Individual consumers had no reliable way to determine if their specific bottle was contaminated. | high |
| 06 | Plaintiff Vivian Makar purchased Angry Orange, used it in her home exposing herself, her husband, and her pets to potential bacterial contamination, and was left unable to safely remediate treated areas without risking adverse chemical reactions from secondary cleaning agents. | med |
Public Health and Safety
Unsafe products and biological hazard
| 01 | Pseudomonas aeruginosa poses a serious infection risk, especially to people with weakened immune systems, underlying lung conditions, or external medical devices. The bacteria can enter the body through inhalation, the eyes, or any break in the skin. | high |
| 02 | The product was marketed as a household cleaner safe for children and pets, meaning it was used in environments with the most vulnerable populations: infants, elderly residents, immunocompromised individuals, and animals. | high |
| 03 | The CPSC directed consumers to stop using the product immediately and to dispose of it. However, consumers who had already applied the product to household surfaces faced a secondary hazard: combining other cleaning chemicals with contaminated residue risked adverse reactions. | high |
| 04 | Consumers who used the product before the recall had no warning they were introducing a bacterial hazard into their homes. Exposure was not limited to the primary purchaser but extended to all household members, visitors, and pets. | med |
Regulatory Failures
How oversight broke down
| 01 | Thrasio failed to adequately design, manufacture, test, inspect, and monitor its production process, allowing contaminated products to enter the market for approximately six years without detection or disclosure. | high |
| 02 | The company failed to warn consumers in a timely manner, allowing adulterated products to remain on retail shelves and in consumer homes for months after any reasonable point of detection. | high |
| 03 | The January 2026 recall notice was not accompanied by a widespread targeted advertising campaign. Direct notice to known purchasers, who could have been identified through Amazon, Walmart, and other platform order histories, was not provided. | med |
| 04 | The CPSC recall covered products manufactured over a period of nearly seven years, indicating that quality control failures were systematic and long-standing, not isolated or accidental. | high |
Corporate Accountability Failures
A recall designed to fail consumers
| 01 | Thrasio’s refund offer requires consumers to photograph the product with “recalled” and their initials written on it in marker and email the photo to a recall address. This process is inaccessible for the majority of class members, who purchased at multiple locations, do not maintain receipts, and may have already used or discarded the product. | high |
| 02 | Consumers who already applied the contaminated product to surfaces in their homes received no compensation for the cost, time, or effort required to re-clean those areas using safe alternatives. The recall remedy does not address this ongoing remediation burden. | high |
| 03 | Thrasio continued to accept and retain consumer payments for products it knew or should have known were contaminated. The company was unjustly enriched by selling goods that posed an unreasonably high risk of bacterial contamination without disclosing that risk. | high |
| 04 | No consumer, had they known of the bacterial contamination risk, would have purchased the product. Every class member who bought Angry Orange Enzyme Stain Remover received a product that had zero value relative to what they paid. The class action argues this constitutes a total failure of consideration. | med |
Economic Fallout
Financial harm to consumers
| 01 | Plaintiff and class members paid between $4 and $60 per unit for a product that was defective and unfit for any household use. The economic benefit they received was worth zero dollars relative to the price paid. | med |
| 02 | The class action exceeds $5 million in controversy under CAFA, representing the aggregate economic loss suffered by 1.5 million units purchased across the nationwide class. | med |
| 03 | Class members face additional unreimbursed costs including the purchase of replacement cleaning products, the time and labor required to re-clean contaminated surfaces, and the cost of any medical evaluation related to potential exposure. | med |
Profit Over People
Revenue prioritized over consumer safety
| 01 | Thrasio derived revenues from the sale of contaminated products and retained those proceeds without disclosing the known or knowable bacterial contamination risk. The lawsuit alleges this retention is unjust and inequitable. | high |
| 02 | The products were sold through major retail platforms at price points ranging from budget to premium, allowing Thrasio to extract maximum revenue across multiple consumer demographics, none of whom were informed of the contamination risk. | med |
| 03 | Thrasio’s recall remedy is structured to minimize financial exposure to the company. By requiring specific documentation most consumers cannot provide, the company effectively limits the number of successful refund claims while retaining the bulk of its revenues. | high |
Timeline of Events
March 2019
Thrasio begins manufacturing what will later be identified as contaminated batches of Angry Orange Enzyme Stain Remover.
2019 to 2025
Approximately 1.5 million units of contaminated product are sold through major retailers and online platforms nationwide while the company markets the product as safe for children and pets.
December 2025
The last contaminated production run ends. Products remain on shelves and in consumer homes.
January 22, 2026
Thrasio announces a voluntary recall in cooperation with the CPSC, citing discovery of Pseudomonas aeruginosa bacterial contamination. The refund process is announced with requirements that effectively exclude most consumers.
February 4, 2026
Plaintiff Vivian Makar files a class action complaint in the U.S. District Court for the Central District of California on behalf of all U.S. purchasers of the recalled product.
Direct Quotes from the Legal Record
Quote 1
Thrasio’s own marketing claims
Core Allegations
“Keeping your children and pets safe is our priority. Unlike other home cleaning products, our Angry Orange cold-pressed formula is chemical-free. We want you to have peace of mind knowing our products are safe to use around your home.”
Why it matters: This was Thrasio’s marketing language while 1.5 million bottles of bacteria-contaminated product were being sold to families. The gap between what the company said and what it sold is the core of the fraud.
Quote 2
Nature of the bacterial hazard
Public Health and Safety
“People with weakened immune systems, external medical devices, or underlying lung conditions who are exposed to Pseudomonas aeruginosa face a risk of serious infection that may require medical treatment.”
Why it matters: This is the CPSC’s own language describing the hazard. The people most at risk, the immunocompromised, the elderly, those with chronic illness, are the same people most likely to use a “gentle” enzyme stain remover marketed as safe.
Quote 3
Six years of failed manufacturing
Regulatory Failures
“Defendant failed to adequately design, manufacture, test, inspect, and monitor the production process of the recalled products, allowing contaminated products to enter the stream of commerce on a massive scale.”
Why it matters: This was not a one-time slip. Six years of contaminated production represents a systemic failure of every quality control mechanism the company was supposed to have in place.
Quote 4
The refund process designed to exclude consumers
Corporate Accountability Failures
“Defendant is aware that most consumers purchase the products at multiple locations and do not maintain receipts. As such, most consumers cannot receive refunds at the location of purchase.”
Why it matters: Thrasio knew its refund process would exclude most consumers. This is not an oversight. Designing a remedy that most people cannot use is a deliberate strategy to minimize corporate financial exposure.
Quote 5
The total worthlessness of what consumers received
Economic Fallout
“Plaintiff and Class Members purchased household products that were represented as safe. Instead, they received adulterated, unsafe, and worthless products that should be discarded, offering no value or benefit relative to their purchase price.”
Why it matters: Every single person who bought this product paid real money for something that was, legally and practically, worth nothing. The full purchase price represents a direct financial loss to millions of consumers.
Quote 6
Unjust enrichment at consumer expense
Profit Over People
“Defendant has been unjustly enriched by retaining the revenues derived from the sales of the potentially contaminated products. Retention of these revenues is inequitable because Defendant failed to disclose the known risks associated with its products, thereby misleading consumers and endangering their safety.”
Why it matters: Thrasio made money from every contaminated bottle sold. That money was obtained through false marketing and a failure to disclose a known health risk. The lawsuit demands that money be returned.
Quote 7
Inadequacy of recall notice
Regulatory Failures
“Notice of the recall was not specifically targeted to reach customers of the products. Unlike class notice (which is designed to reach the majority of class members), Defendant has not conducted a widespread advertising campaign or provided direct notice to known purchasers.”
Why it matters: Thrasio has the sales data. It knows who bought this product through Amazon and major retailers. Choosing not to directly notify those purchasers means countless people are still using contaminated product today.
Commentary
Is this a serious lawsuit, or is it opportunistic litigation?
▾
This case is grounded in a documented, government-confirmed recall. The CPSC officially recognized the contamination and issued a public recall notice. Thrasio itself acknowledged the problem by initiating the recall and establishing a refund process. The class action exists because the recall remedy is structurally inadequate. The lawsuit adds legal force to a real, documented harm affecting 1.5 million units of product. This is not speculation. This is a company that sold contaminated goods for six years while marketing them as safe.
Who is most at risk from Pseudomonas aeruginosa?
▾
People with weakened immune systems, underlying lung conditions such as COPD or cystic fibrosis, external medical devices such as catheters, and anyone with a skin wound or abrasion are most vulnerable. The bacteria can enter through inhalation, the eyes, or broken skin. Children and pets, the very populations Thrasio claimed to protect, were also in the exposure zone of every household using this product.
Why is the recall remedy inadequate?
▾
The refund process requires consumers to take a specific photo of the product with “recalled” and their initials written on it and email it to a recall address. Most people don’t still have the bottle, don’t keep receipts, and bought the product in multiple locations over six years. Thrasio knows this. Beyond the refund, consumers who already used the product on surfaces in their homes received nothing for the cost and labor of re-cleaning those surfaces. The recall is structured to minimize Thrasio’s financial exposure, not to make consumers whole.
Did Thrasio know about the contamination before the recall?
▾
The complaint alleges Thrasio “knew or should have known” about the contamination risk given its role as manufacturer and distributor. The six-year span of contaminated production is not consistent with a sudden, isolated defect. It indicates that adequate testing and quality control were not in place, and that the company failed to catch or disclose a systemic problem. Whether Thrasio had actual knowledge before the recall is a question the court will examine. What is already established is that the failure of oversight was severe and long-running.
What does this case say about how e-commerce companies handle product safety?
▾
Thrasio is a rollup company built on acquiring Amazon-native brands and scaling them. Its business model prioritizes rapid growth and revenue extraction. This case illustrates what happens when that model is applied to consumer product categories with real safety obligations and no meaningful investment in quality assurance. The contamination ran for six years. The recall notice reached only a fraction of buyers. The remedy was structured to fail most claimants. This is what corporate accountability looks like when it is outsourced to a recall form and an email address.
What can I do if I purchased Angry Orange Enzyme Stain Remover?
▾
Stop using the product immediately. Do not attempt to re-use or redistribute it. You can attempt to claim a refund by emailing a photo of the product with “recalled” and your initials written on it to productrecall@angryorange.com, though this process has significant limitations. Monitor for symptoms of Pseudomonas aeruginosa infection, particularly if you are immunocompromised. If you believe you or a household member was harmed, consult a physician. You may also be entitled to participate in the class action: contact an attorney or monitor ClassAction.org for updates on the case (Case 2:26-cv-01176, C.D. Cal.).
What can I do to prevent this from happening again?
▾
Support mandatory pre-market microbial testing requirements for household cleaning products. Urge your representatives to strengthen CPSC enforcement authority and require companies to directly notify known purchasers in all consumer product recalls. Follow and share independent product safety reporting, since industry self-policing clearly failed here for six years. When companies like Thrasio face real legal and financial consequences through class actions, the cost calculus around cutting corners on safety changes. Share this article. Report product safety concerns to the CPSC at SaferProducts.gov.
What specific damages is the class seeking?
▾
The class action seeks compensatory, statutory, and punitive damages; restitution and disgorgement of Thrasio’s profits from contaminated product sales; injunctive relief requiring enhanced safety testing and improved recall remedies; and attorneys’ fees. The complaint also requests that the class be certified and that Thrasio be enjoined from continuing conduct that violates consumer protection law. Every class member is entitled to at minimum a full refund of the purchase price, along with compensation for remediation costs.
The federal government has a recall notice for this product that you can check out: https://www.cpsc.gov/Recalls/2026/Thrasio-Recalls-Angry-Orange-Enzyme-Stain-Removers-Due-to-Risk-of-Exposure-to-Bacteria
💡 Explore Corporate Misconduct by Category
Corporations harm people every day — from wage theft to pollution. Learn more by exploring key areas of injustice.
- 💀 Product Safety Violations — When companies risk lives for profit.
- 🌿 Environmental Violations — Pollution, ecological collapse, and unchecked greed.
- 💼 Labor Exploitation — Wage theft, worker abuse, and unsafe conditions.
- 🛡️ Data Breaches & Privacy Abuses — Misuse and mishandling of personal information.
- 💵 Financial Fraud & Corruption — Lies, scams, and executive impunity.
